The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat
NCT ID: NCT05520021
Last Updated: 2022-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2022-09-01
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa
NCT03542552
Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection
NCT02506894
Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia
NCT02307201
A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy
NCT02032186
Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial
NCT03318211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Magnesium sulfate treatment
A total of 30 pregnancies with preterm labor threats will be treated with Magnesium sulfate.
Magnesium sulfate
A total of 30 pregnancies with preterm labor threats will be treated with Magnesium sulfate.
Nifedipine treatment
A total of 30 pregnancies with preterm labor threats will be treated with Nifedipine.
Nifedipine
A total of 30 pregnancies with preterm labor threats will be treated with Nifedipine.
Healthy pregnant women
A total of 30 pregnancies without preterm labor threat will be included.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nifedipine
A total of 30 pregnancies with preterm labor threats will be treated with Nifedipine.
Magnesium sulfate
A total of 30 pregnancies with preterm labor threats will be treated with Magnesium sulfate.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Multiple pregnancies,
* Pregnancy complications including preeclampsia, ablatio placenta, intrauterine growth restriction, placenta previa, gestational diabetes
18 Years
38 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Konya Meram State Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hasan Ali Inal, MD
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hasan A Inal
Role: PRINCIPAL_INVESTIGATOR
Antalya Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasan Ali Inal
Antalya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
351507
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.